C4 Therapeutics, Inc. (CCCC) News & Overview - Discounting Cash Flows
CCCC
C4 Therapeutics, Inc.
CCCC (NASDAQ)

CCCC's Business Model

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma. The company is also developing CFT8634, an orally bioavailable BiDAC degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid tumors; CFT1946, an orally bioavailable BiDAC degrader targeting V600X mutant BRAF to treat melanoma, non-small cell lung cancer (NSCLC), colorectal cancer, and other solid malignancies; CFT8919, an orally bioavailable, allosteric, and mutant-selective BiDAC degrader of epidermal growth factor receptor, or EGFR, with an L858R mutation in NSCLC; and earlier stage programs comprising RET degraders for the treatment of various cancers. C4 Therapeutics, Inc. has strategic collaborations with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; Biogen MA, Inc.; and Calico Life Sciences LLC. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Sector & Industry Healthcare / Biotechnology
Website https://www.c4therapeutics.com
CEO (Chief Executive Officer) Andrew J. Hirsch
Number of Employees
IPO date October 2, 2020

CCCC Latest News

Contact
CountryUS
Address490 Arsenal Way
CityWatertown
StateMA
Phone617 231 0700
Zip Code02472
Other Identifiers
CIK0001662579
ISINUS12529R1077
CUSIP12529R107
Open1.955
Previous Close1.99
Volume3.97 Mil.
Average Volume1.27 Mil.
Day’s Range1.94 – 2.405
52 Week Range1.085-7.66
MA (50)1.5174
MA (200)3.2098
Market Cap158.3 Mil.
Shares Out.71.01 Mil.
Earnings DateAug 07, 2025
Beta
Last Dividend
EPS
PE

Industry Competitors for CCCC

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us